Romanian drug manufacturer Antibiotice Iasi reported a net profit of RON 74.194 million in H1 2024, 19.66 percent up year-over-year, according to a report sent on Wednesday to the Bucharest Stock Exchange. The company’s net turnover (revenues from contracts with clients) as of end-June 2024 amounted to RON 350.85 million (plus 11.07 percent), of which […]
Sursa: Ecopoliticnews.com
